Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review
äºBeneficial MicrobesSearch for other papers by V.N. Dargenio in
Current site
Google Scholar
Search for other papers by F. Cristofori in
Current site
Google Scholar
Search for other papers by C. Dargenio in
Current site
Google Scholar
Search for other papers by P. Giordano in
Current site
Google Scholar
Search for other papers by F. Indrio in
Current site
Google Scholar
Search for other papers by G. Celano in
Current site
Google Scholar
Search for other papers by R. Francavilla in
Current site
Google Scholar
Strains of lactobacilli are the most widely used probiotics and can be found in a large variety of food products and food supplements throughout the world. In this study, the evidence on Limosilactobacillus reuteri DSM 17938 (LR DSM 17938) has been reviewed. This species secretes reuterin and other substances singularly or in microvesicles, inhibiting pathogen growth and interacting with the intestinal microbiota and mucosa, restoring homeostasis. The use of LR DSM 17938 has been exploited in several pathological conditions. Preclinical research has shown that this probiotic can ameliorate dysbiosis and, by interacting with intestinal mucosal cells, can raise the pain threshold and promote gastrointestinal motility. These aspects are amongst the significant components in functional gastrointestinal disorders, such as colic and regurgitation in infants, functional abdominal pain and functional constipation in children and adolescents. This strain can decrease the duration of acute diarrhoea and hospitalization for acute gastroenteritis but does not seem to prevent nosocomial diarrhoea and antibiotic-associated diarrhoea. Because of its ability to survive in the gastric environment, it has been tested in Helicobacter pylori infection, showing a significant decrease of antibiotic-associated side effects and a tendency to increase the eradication rate. Finally, all these studies have shown the excellent safety of LR DSM 17938 even at higher dosages. In conclusion data from various clinical trials here reviewed can guide the clinician to find the correct dose, frequency of administration, and therapy duration.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Ahmadi, E., Alizadeh-Navaei, R. and Rezai, M.S., 2015. Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis. Caspian Journal of Internal Medicine 6:187-195.
'Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis ' () 6 Caspian Journal of Internal Medicine : 187 -195.
-
Alam, S. and Mushtaq, M., 2009. Antibiotic associated diarrhea in children. Indian Pediatrics 46: 491-496.
'Antibiotic associated diarrhea in children ' () 46 Indian Pediatrics : 491 -496.
-
Alfarouk, K.O., Bashir, A.H.H., Aljarbou, A.N., Ramadan, A.M., Muddathir, A.K., AlHoufie, S.T.S., Hifny, A., Elhassan, G.O., Ibrahim, M.E., Alqahtani, S.S., AlSharari, S.D., Supuran, C.T., Rauch, C., Cardone, R.A., Reshkin, S.J., Fais, S. and Harguindey, S., 2019. The possible role of Helicobacter pyloriin gastric cancer and its management. Frontiers in Oncology 9: 75. https://doi.org/10.3389/fonc.2019.00075
-
Allen, S.J., Martinez, E.G. Gregorio, G. V. and Dans, L.F., 2010. Probiotics for treating acute infectious diarrhoea. Cochrane Database of Systematic Reviews 2010. https://doi.org/10.1002/14651858.CD003048.pub3
-
Applegate, J.A., Fischer Walker, C.L., Ambikapathi, R. and Black, R.E., 2013. Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children. BMC Public Health 13: S16. https://doi.org/10.1186/1471-2458-13-S3-S16
-
Assa, A., Ish-Tov, A., Rinawi, F. and Shamir, R., 2015. School attendance in children with functional abdominal pain and inflammatory bowel diseases. Journal of Pediatric Gastroenterology and Nutrition 61: 553-557. https://doi.org/10.1097/MPG.0000000000000850
-
Benninga, M.A., Nurko, S., Faure, C., Hyman, P.E., St James Roberts, I. and Schechter, N.L., 2016. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 150: 1443-1455.e2. https://doi.org/10.1053/j.gastro.2016.02.016
-
Cameron, D., Hock, Q.S., Kadim, M., Mohan, N., Ryoo, E., Sandhu, B., Yamashiro, Y., Jie, C., Hoekstra, H. and Guarino, A., 2017. Probiotics for gastrointestinal disorders: proposed recommendations for children of the Asia-Pacific region. World Journal of Gastroenterology 23: 7952-7964. https://doi.org/10.3748/wjg.v23.i45.7952
-
Cannon, J.P., Lee, T.A., Bolanos, J.T. and Danziger, L.H., 2005. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. European Journal of Clinical Microbiology and Infectious Diseases 24: 31-40. https://doi.org/10.1007/s10096-004-1253-y
-
Chau, K., Lau, E., Greenberg, S., Jacobson, S., Yazdani-Brojeni, P., Verma, N. and Koren, G., 2015. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. Journal of Pediatrics 166: 74-78. e1. https://doi.org/10.1016/j.jpeds.2014.09.020
-
Chen, C.C. and Walker, W.A., 2011. Clinical applications of probiotics in gastrointestinal disorders in children. National Medical Journal of India 24: 153-160.
'Clinical applications of probiotics in gastrointestinal disorders in children ' () 24 National Medical Journal of India : 153 -160.
-
Chichlowski, M., Rudolph, C., 2015. Visceral pain and gastrointestinal microbiome. Journal of Neurogastroenterology and Motility 21: 172-181. https://doi.org/10.5056/jnm15025
-
Chung, T.C., Axelsson, L., Lindgren, S.E., Dobrogosz, W.J., 1989. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microbial Ecology in Health and Disease 2: 137-144. https://doi.org/10.3109/08910608909140211
-
Ciandrini, E., Campana, R., Casettari, L., Perinelli, D.R., Fagioli, L., Manti, A., Palmieri, G.F., Papa, S. and Baffone, W., 2016. Characterization of biosurfactants produced by Lactobacillus spp. and their activity against oral streptococci biofilm. Applied Microbiology and Biotechnology 100: 6767-6777. https://doi.org/10.1007/S00253-016-7531-7
-
Ciciora, S.L. and Woodley, F.W., 2018. Optimizing the use of medications and other therapies in infant gastroesophageal reflux. Pediatric Drugs 20: 523-537. https://doi.org/10.1007/s40272-018-0311-3
-
Coccorullo, P., Strisciuglio, C., Martinelli, M., Miele, E., Greco, L. and Staiano, A., 2010. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: A double-blind, randomized, placebo-controlled study. Journal of Pediatrics 157: 598-602. https://doi.org/10.1016/j.jpeds.2010.04.066
-
Coté, G.A. and Buchman, A.L., 2006. Antibiotic-associated diarrhoea. Expert Opinion on Drug Safety 5: 361-372. https://doi.org/10.1517/14740338.5.3.361
-
Cristofori, F., Dargenio, V.N., Dargenio, C., Miniello, V.L., Barone, M. and Francavilla, R., 2021. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Frontiers in Immunology 12: 578386. https://doi.org/10.3389/fimmu.2021.578386
-
Cruchet, S., Furnes, R., Maruy, A., Hebel, E., Palacios, J., Medina, F., Ramirez, N., Orsi, M., Rondon, L., Sdepanian, V., Xóchihua, L., Ybarra, M. and Zablah, R.A., 2015. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Pediatric Drugs 17: 199-216. https://doi.org/10.1007/s40272-015-0124-6
-
Czinn, S.J. and Blanchard, S., 2013. Gastroesophageal reflux disease in neonates and infants: when and how to treat. Pediatric Drugs 15: 19-27. https://doi.org/10.1007/s40272-012-0004-2
-
Dargenio, C., Dargenio, V.N., Bizzoco, F., Indrio, F., Francavilla, R. and Cristofori, F., 2021. Limosilactobacillus reuteri strains as adjuvants in the management of Helicobacter pylori infection. Medicina 57: 733. https://doi.org/10.3390/medicina57070733
-
Davies, I., Burman-Roy, S and Murphy, M.S., 2015. Gastro-oesophageal reflux disease in children: NICE guidance. BMJ 350: g7703. https://doi.org/10.1136/bmj.g7703
-
De Meij, T.G.J., De Groot, E.F.J., Eck, A., Budding, A.E., Kneepkens, B.M.F., Benninga, M.A., Van Bodegraven, A.A. and Savelkoul, P.H.M., 2016. Characterization of microbiota in children with chronic functional constipation. PLoS ONE 11: e0164731. https://doi.org/10.1371/journal.pone.0164731
-
De Moraes, J.G., De Almeida Motta, M.E.F., de Sa Beltrão, M.F., Salviano, T.L. and Da Silva, G.A.P., 2016. Fecal microbiota and diet of children with chronic constipation. International Journal of Pediatrics 2016: 6787269. https://doi.org/10.1155/2016/6787269
-
Dhroove, G., Chogle, A. and Saps, M., 2010. A million-dollar work-up for abdominal pain: Is it worth it? Journal of Pediatric Gastroenterology and Nutrition 51: 579-583. https://doi.org/10.1097/MPG.0b013e3181de0639
-
Dinleyici, E.C., Dalgic, N., Guven, S., Metin, O., Yasa, O., Kurugol, Z., Turel, O., Tanir, G., Yazar, A.S., Arica, V., Sancar, M., Karbuz, A., Eren, M., Ozen, M., Kara, A. and Vandenplas, Y., 2015. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. Jornal de Pediatria 91: 392-396. https://doi.org/10.1016/j.jped.2014.10.009
-
Dinleyici, E.C. and Vandenplas, Y., 2014. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatrica 103: e300-e305. https://doi.org/10.1111/apa.12617
-
Dommels, Y.E.M., Kemperman, R.A., Zebregs, Y.E.M.P., Draaisma, R.B., Jol, A., Wolvers, D.A.W., Vaughan, E.E. and Albers, R., 2009. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Applied and Environmental Microbiology 75: 6198-6204. https://doi.org/10.1128/AEM.01054-09
-
Dore, M.P., Bibbò, S., Pes, G.M., Francavilla, R. and Graham, D.Y., 2019. Role of probiotics in Helicobacter pylori eradication: lessons from a study of Lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a proton-pump inhibitor. Canadian Journal of Infectious Diseases and Medical Microbiology 2019: 3409820. https://doi.org/10.1155/2019/3409820
-
Dore, M.P., Cuccu, M., Pes, G.M., Manca, A. and Graham, D.Y., 2014. Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Internal and Emergency Medicine 9: 649-654. https://doi.org/10.1007/s11739-013-1013-z
-
Dore, M. P., Goni, E. and Di Mario, F., 2015. Is there a role for probiotics in Helicobacter pylori therapy? Gastroenterology Clinics of North America 44: 565-575. https://doi.org/10.1016/j.gtc.2015.05.005
-
Drossman, D.A., 2016. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 150: 1262-1279.e2. https://doi.org/10.1053/j.gastro.2016.02.032
-
Dryl, R. and Szajewska, H., 2018. Probiotics for management of infantile colic: a systematic review of randomized controlled trials. Archives of Medical Science 14: 1137-1143. https://doi.org/10.5114/AOMS.2017.66055
-
Duar, R.M., Lin, X.B., Zheng, J., Martino, M.E., Grenier, T., Pérez-Muñoz, M.E., Leulier, F. and Gänzle, M., Walter, J., 2017. Lifestyles in transition: evolution and natural history of the genus Lactobacillus. FEMS Microbiology Reviews 41: S27-S48. https://doi.org/10.1093/femsre/fux030
-
Ducrotté, P., Sawant, P. and Jayanthi, V., 2012. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World Journal of Gastroenterology 18: 4012-4018. https://doi.org/10.3748/wjg.v18.i30.4012
-
Eftekhari, K., Vahedi, Z., Aghdam, M.K. and Diaz, D.N., 2015. A randomized double-blind placebo-controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics 25: e2616. https://doi.org/10.5812/ijp.2616
-
Fatheree, N.Y., Liu, Y., Taylor, C.M., Hoang, T.K., Cai, C., Rahbar, M.H., Hessabi, M., Ferris, M., McMurtry, V., Wong, C., Vu, T., Dancsak, T., Wang, T., Gleason, W., Bandla, V., Navarro, F., Tran, B.Q. and Rhoads, J.M., 2017. Lactobacillus reuteri for infants with colic: a double-blind, placebo-controlled, randomized clinical trial. Journal of Pediatrics 191: 170-178.e2. https://doi.org/10.1016/j.jpeds.2017.07.036
-
Florez, I.D., Veroniki, A.A., Al Khalifahn, R., Yepes-Nuñez, J.J., Sierra, J.M., Vernooij, R.W.M., Acosta-Reyes, J., Granados, C.M., Perez-Gaxiolan, G., Cuello-Garcia, C., Zea, A.M., Zhang, Y., Foroutan, N., Guyatt, G.H. and Thabane, L., 2018. Comparative effectiveness and safety of interventions for acute diarrhea and gastroenteritis in children: a systematic review and network meta-analysis. PLoS ONE 13: e0207701. https://doi.org/10.1371/journal.pone.0207701
-
Francavilla, R., Lionetti, E., Castellaneta, S., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C., La Rosa, M.M., Cavallo, L. and Francavilla, A., 2012. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study. Alimentary Pharmacology and Therapeutics 36: 363-369. https://doi.org/10.1111/J.1365-2036.2012.05180.X
-
Francavilla, R., Polimeno, L., Demichina, A., Maurogiovanni, G., Principi, B., Scaccianoce, G., Ierardi, E., Russo, F., Riezzo, G., Di Leo, A., Cavallo, L., Francavilla, A. and Versalovic, J., 2014. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. Journal of Clinical Gastroenterology 48: 407-413. https://doi.org/10.1097/MCG.0000000000000007
-
Freedman, S.B., Pasichnyk, D., Black, K.J.L., Fitzpatrick, E., Gouin, S., Milne, A., Hartling, L., Johnson, D., Robert, R., Joubert, G., Doan, Q., Williamson, J., Aucoin, L., Jabbour and M., Klassen, T., 2015. Gastroenteritis therapies in developed countries: systematic review and meta-analysis. PLoS ONE 10: e0128754. https://doi.org/10.1371/journal.pone.0128754
-
Fuccio, L., Minardi, M.E., Zagari, R.M., Grilli, D., Magrini, N. and Bazzoli, F., 2007. Meta-analysis: duration of first-line protonpump inhibitor-based triple therapy for Helicobacter pylori eradication. Annals of Internal Medicine 147: 553-562. https://doi.org/10.7326/0003-4819-147-8-200710160-00008
-
Garofoli, F., Civardi, E., Indrio, F., Mazzucchelli, I., Angelini, M., Tinelli, C.and Stronati, M., 2014. The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. International Journal of Food Sciences and Nutrition 65: 646-648. https://doi.org/10.3109/09637486.2014.898251
-
Georgieva, M., Pancheva, R., Rasheva, N., Usheva, N., Ivanova, L. and Koleva, K., 2015. Use of the probiotic Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated infections in Bulgarian children: a randomized, controlled trial. Journal of IMAB â Annual Proceeding 21: 895-900. https://doi.org/10.5272/jimab.2015214.895
-
Gibson, M.K., Crofts, T.S. and Dantas, G., 2015. Antibiotics and the developing infant gut microbiota and resistome. Current Opinion in Microbiology 27: 51-56. https://doi.org/10.1016/j.mib.2015.07.007
-
Giraffa, G., Chanishvili, N. and Widyastuti, Y., 2010. Importance of lactobacilli in food and feed biotechnology. Research in Microbiology 161: 480-487. https://doi.org/10.1016/j.resmic.2010.03.001
-
Guarino, A., Ashkenazi, S., Gendrel, D., Lo Vecchio, A., Shamir, R. and Szajewska, H., 2014. European society for pediatric gastroenterology, hepatology, and nutrition/European society for pediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. Journal of Pediatric Gastroenterology and Nutrition 59: 132-152. https://doi.org/10.1097/MPG.0000000000000375
-
Guarino, A., Vecchio, A. Lo, Dias, J.A., Berkley, J.A., Boey, C., Bruzzese, D., Cohen, M.B., Cruchet, S., Liguoro, I., Salazar-Lindo, E., Sandhu, B., Sherman, P.M. and Shimizu, T., 2018. Universal recommendations for the management of acute diarrhea in nonmalnourished children. Journal of Pediatric Gastroenterology and Nutrition 67: 586-593. https://doi.org/10.1097/MPG.0000000000002053
-
Guarino, M.P.L., Altomare, A., Stasi, E., Marignani, M., Severi, C., Alloni, R., Dicuonzo, G., Morelli, L., Coppola, R. and Cicala, M., 2008. Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells. Journal of Clinical Gastroenterology 42 Suppl. 3: S185-S190. https://doi.org/10.1097/mcg.0b013e31817e1cac
-
Gutierrez-Castrellon, P., Lopez-Velazquez, G., Diaz-Garcia, L., Jimenez-Gutierrez, C., Mancilla-Ramirez, J., Estevez-Jimenez, J. and Parra, M., P., 2014. Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 133: e904-e909. https://doi.org/10.1542/PEDS.2013-0652
-
Gutiérrez-Castrellón, P., OrtÃz-Hernández, A.A., Llamosas-Gallardo, B., Acosta-Bastidas, M.A., Jiménez-Gutiérrez, C., Diaz-GarcÃa, L., Anzo-Osorio, A., Estevez-Jiménez, J., Jiménez-Escobar, I. and Vidal-Vázquez, R.P., 2015. Efficacy of racecadotril vs smectite, probiotics or zinc as an integral part of the treatment of acute diarrhoea in children under five years: a meta-analysis of multiple treatments. Gaceta Medica de Mexico 151: 329-337.
'Efficacy of racecadotril vs smectite, probiotics or zinc as an integral part of the treatment of acute diarrhoea in children under five years: a meta-analysis of multiple treatments ' () 151 Gaceta Medica de Mexico : 329 -337.
-
Haileselassie, Y., Navis, M., Vu, N., Qazi, K.R., Rethi, B. and Sverremark-Ekström, E., 2016. Postbiotic modulation of retinoic acid imprinted mucosal-like dendritic cells by probiotic Lactobacillus reuteri 17938 in vitro. Frontiers in Immunology 7: 96. https://doi.org/10.3389/fimmu.2016.00096
-
He, B., Hoang, T.K., Tian, X., Taylor, C.M., Blanchard, E., Luo, M., Bhattacharjee, M.B., Freeborn, J., Park, S., Couturier, J., Lindsey, J.W., Tran, D.Q., Rhoads, J.M. and Liu, Y., 2019. Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Frontiers in Immunology 10: 385. https://doi.org/10.3389/FIMMU.2019.00385
-
Hegar, B., Dewanti, N.R., Kadim, M., Alatas, S., Firmansyah, A. and Vandenplas, Y., 2009. Natural evolution of regurgitation in healthy infants. Acta Paediatrica 98: 1189-1193. https://doi.org/10.1111/j.1651-2227.2009.01306.x
-
Heimbach, J., BioGaia AB, 2008. GRAS Notice 000254: Generally Recognized as Safe (GRAS) determination of Lactobacillus reuteri strain DSM 17938. Center for Food Safety and Applied Nutrition, Food and Drug Administration, Silver Spring, MD, USA.
'GRAS Notice 000254: Generally Recognized as Safe (GRAS) determination of Lactobacillus reuteri strain DSM 17938', ().
-
Helmons, P.J., Coates, C.R., Kosterink, J.G.W. and Daniels, C.E., 2015. Decision support at the point of prescribing to increase formulary adherence. American Journal of Health-System Pharmacy 72: 408-413. https://doi.org/10.2146/ajhp140388
-
Hoang, T.K., Freeborn, J., Wang, T., Mai, T., He, B., Park, S., Tran, D.Q., Roos, S., Rhoads, J.M. and Liu, Y., 2019. Human breast milk promotes the immunomodulatory function of probiotic Lactobacillus reuteri DSM 17938 in the neonatal rat intestine. Journal of Probiotics & Health 7: 210. https://doi.org/10.35248/2329-8901.19.7.210
-
Hoang, T.K., He, B., Wang, T., Tran, D.Q., Rhoads, J.M. and Liu, Y., 2018. Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2. American Journal of Physiology â Gastrointestinal and Liver Physiology 315: G231-G240. https://doi.org/10.1152/AJPGI.00084.2017
-
Högenauer, C., Hammer, H.F., Krejs, G.J. and Reisinger, E.C., 1998. Mechanisms and management of antibiotic-associated diarrhea. Clinical Infectious Diseases 27: 702-710. https://doi.org/10.1086/514958
-
Hojsak, I., Fabiano, V., Pop, T.L., Goulet, O., Zuccotti, G.V., ÃokuÄraÅ, F.C., Pettoello-Mantovani and M., Kolacek, S., 2018a. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Paediatrica 107: 927-937. https://doi.org/10.1111/apa.14270
-
Hojsak, I., Szajewska, H., Canani, R.B., Guarino, A., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., Van Goudoever, J.B. and Weizman, Z., 2018b. Probiotics for the prevention of nosocomial diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition 66: 3-9. https://doi.org/10.1097/MPG.0000000000001637
-
Hooi, J.K.Y., Lai, W.Y., Ng, W.K., Suen, M.M.Y., Underwood, F.E., Tanyingoh, D., Malfertheiner, P., Graham, D.Y., Wong, V.W.S., Wu, J.C.Y., Chan, F.K.L., Sung, J.J.Y., Kaplan, G.G. and Ng, S.C., 2017. Global Prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153: 420-429. https://doi.org/10.1053/j.gastro.2017.04.022
-
Hoy-Schulz, Y.E., Jannat, K., Roberts, T., Zaidi, S.H., Unicomb, L., Luby, S. and Parsonnet, J., 2016. Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial. BMC Complementary and Alternative Medicine 16: 44. https://doi.org/10.1186/s12906-016-1016-1
-
Hou, C., Zeng, X., Yang, F., Liu, H., & Qiao, S, 2015. Study and use of the probiotic Lactobacillus reuteri in pigs: a review. Journal of Animal Science and Biotechnology 6: 14. https://doi.org/10.1186/s40104-015-0014-3
-
Hyams, J.S., Di Lorenzo, C., Saps, M., Shulman, R.J., Staiano, A. and Van Tilburg, M., 2016. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 150: 1456-1468.e2. https://doi.org/10.1053/j.gastro.2016.02.015
-
Indrio, F., Dargenio, V.N., Giordano, P. and Francavilla, R., 2019. Preventing and treating colic. In: Guandalini, S. and Indrio, F. (eds.) Probiotics and child gastrointestinal health. Advances in experimental medicine and biology, vol. 10. Springer, Berlin, Germany, pp. 49-56. https://doi.org/10.1007/5584_2018_315
-
Indrio, F., Di Mauro, A., Riezzo, G., Civardi, E., Intini, C., Corvaglia, L., Ballardini, E., Bisceglia, M., Cinquetti, M., Brazzoduro, E., Del Vecchio, A., Tafuri, S. and Francavilla, R., 2014. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatrics 168: 228-233. https://doi.org/10.1001/JAMAPEDIATRICS.2013.4367
-
Indrio, F., Riezzo, G., Giordano, P., Ficarella, M., Miolla, M.P., Martini, S., Corvaglia, L. and Francavilla, R., 2017. Effect of a partially hydrolysed whey infant formula supplemented with starch and Lactobacillus reuteri DSM 17938 on regurgitation and gastric motility. Nutrients 9: 1181. https://doi.org/10.3390/nu9111181
-
Indrio, F., Riezzo, G., Raimondi, F., Bisceglia, M., Cavallo, L. and Francavilla, R., 2008. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. Journal of Pediatrics 152: 801-806. https://doi.org/10.1016/j.jpeds.2007.11.005
-
Indrio, F., Riezzo, G., Raimondi, F., Bisceglia, M., Filannino, A., Cavallo, L. and Francavilla, R., 2011. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. European Journal of Clinical Investigation 41: 417-422. https://doi.org/10.1111/j.1365-2362.2010.02425.x
-
Iramain, R., Jara, A., Martinez Tovilla, Y., Cardozo, L., Morinigo, R., Rojas, P., Bogado, N., Rolon, P., Flecha, C., Amado, A., Lasso, R., Solis, K., Galvis, L. and De Jesús, R., 2017. Consensus guideline on acute gastroenteritis in the emergency department. Emergency Medicine Committee of SLACIP (Latin American Society of Pediatric Intensive Care). PediatrÃa 44: 249-258. https://doi.org/10.18004/ped.2017.diciembre.249-258
-
JadreÅ¡in, O., Hojsak, I., MiÅ¡ak, Z., Kekez, A.J., TrbojeviÄ, T., IvkoviÄ, L. and KolaÄek, S., 2017. Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study. Journal of Pediatric Gastroenterology and Nutrition 64: 925-929. https://doi.org/10.1097/MPG.0000000000001478
-
JadreÅ¡in, O., Sila, S., TriviÄ, I., MiÅ¡ak, Z., KolaÄek, S., 2018. Lack of benefit of Lactobacillus reuteri DSM 17938 as an addition to the treatment of functional constipation. Journal of Pediatric Gastroenterology and Nutrition 67: 763-766. https://doi.org/10.1097/MPG.0000000000002134
-
Jadresin, O., Sila, S., Trivic, I., Misak, Z., Kolacek, S. and Hojsak, I., 2020. Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: results of the double-blind randomized study. Clinical Nutrition 39: 3645-3651. https://doi.org/10.1016/j.clnu.2020.04.019
-
Johansson, M.A., Björkander, S., Forsberg, M.M., Qazi, K.R., Celades, M. S., Bittmann, J., Eberl, M. and Sverremark-Ekström, E., 2016. Probiotic lactobacilli modulate Staphylococcus aureus-induced activation of conventional and unconventional T cells and NK cells. Frontiers in Immunology 7: 273. https://doi.org/10.3389/fimmu.2016.00273
-
Jørgensen, M.R., Kragelund, C., Jensen, P.Ã., Keller, M.K. and Twetman, S., 2017. Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro. Journal of Oral Microbiology 9: 1274582. https://doi.org/10.1080/20002297.2016.1274582
-
Karafillakis, E., Hassounah, S. and Atchison, C., 2015. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine 33: 2097-2107. https://doi.org/10.1016/j.vaccine.2015.03.016
-
Karimi, S., Jonsson, H., Lundh, T. and Roos, S., 2018. Lactobacillus reuteri strains protect epithelial barrier integrity of IPEC-J2 monolayers from the detrimental effect of enterotoxigenic Escherichia coli. Physiological Reports 6: e13514. https://doi.org/10.14814/phy2.13514
-
Karvonen, A., Casas, I. and Vesikari, T., 2001. Safety and possible anti-diarrhoeal effect of the probiotic Lactobacillus reuteri after oral administration to neonates. Poster presented at the 23rd ESPEN congress, Munich, Germany.
Safety and possible anti-diarrhoeal effect of the probiotic Lactobacillus reuteri after oral administration to neonates
-
Keefe, M.R., Kajrlsen, K.A., Lobo, M.L., Kotzer, A.M. and Dudley, W.N., 2006. Reducing parenting stress in families with irritable infants. Nursing Research 55: 198-205. https://doi.org/10.1097/00006199-200605000-00006
-
Kolodziej, M. and Szajewska, H., 2019. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial. Clinical Microbiology and Infection 25: 699-704. https://doi.org/10.1016/J.CMI.2018.08.017
-
Kosek, M.N., Peñataro-Yori, P., Paredes-Olortegui, M., Lefante, J., Ramal-Asayag, C., Zamora-Babilonia, M., Meza-Sanchez, G. and Oberhelman, R.A., 2019. Safety of Lactobacillus reuteri DSM 17938 in healthy children 2-5 years of age. Pediatric Infectious Disease Journal 38: E178-E180. https://doi.org/10.1097/INF.0000000000002267
-
Kruis, W., FriÄ, P., Pokrotnieks, J., Lukáš, M., Fixa, B., KaÅ¡Äák, M., Kamm, M.A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C. and Schulze, J., 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623. https://doi.org/10.1136/gut.2003.037747
-
KÅ¡onžeková, P., Bystrický, P., VlÄková, S., Pätoprstý, V., Pulzová, L., MudroÅová, D., KubaÅ¡ková, T., Csank, T. and TkáÄiková, L., 2016. Exopolysaccharides of Lactobacillus reuteri: their influence on adherence of E. coli to epithelial cells and inflammatory response. Carbohydrate Polymers 141: 10-19. https://doi.org/10.1016/j.carbpol.2015.12.037
-
Kubota, M., Ito, K., Tomimoto, K., Kanazaki, M., Tsukiyama, K., Kubota, A., Kuroki, H., Fujita, M. and Vandenplas, Y., 2020. Lactobacillus reuteri DSM 17938 and magnesium oxide in children with functional chronic constipation: A double-blind and randomized clinical trial. Nutrients 12: 225. https://doi.org/10.3390/nu12010225
-
Lebeer, S., Vanderleyden, J. and De Keersmaecker, S.C.J., 2008. Genes and molecules of lactobacilli supporting probiotic action. Microbiology and Molecular Biology Reviews 72: 728-764. https://doi.org/10.1128/mmbr.00017-08
-
Lightdale, J.R., Gremse, D.A., Heitlinger, L.A., Cabana, M., Gilger, M.A., Gugig, R. and Hill, I.D., 2013. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics 131: e1684-95. https://doi.org/10.1542/peds.2013-0421
-
Lin, Y.P., Thibodeaux, C.H., Peña, J.A., Ferry, G.D. and Versalovic, J., 2008. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflammatory Bowel Diseases 14: 1068-1083. https://doi.org/10.1002/ibd.20448
-
Liu, Y., Fatheree, N.Y., Dingle, B.M., Tran, D.Q. and Rhoads, J.M., 2013. Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS ONE 8: e56547. https://doi.org/10.1371/JOURNAL.PONE.0056547
-
Liu, Y., Fatheree, N.Y., Mangalat, N. and Rhoads, J.M., 2010. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. American Journal of Physiology â Gastrointestinal and Liver Physiology 299: 1087-1096. https://doi.org/10.1152/ajpgi.00124.2010
-
Liu, Y., Fatheree, N.Y., Mangalat, N. and Rhoads, J.M., 2012. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. American Journal of Physiology â Gastrointestinal and Liver Physiology 302: G608-G617. https://doi.org/10.1152/AJPGI.00266.2011
-
Liu, Y., Hoang, T.K., Taylor, C.M., Park, E.S., Freeborn, J., Luo, M., Roos, S. and Rhoads, J.M., 2021. Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg-deficiency. American Journal of Physiology â Gastrointestinal and Liver Physiology 320: G969-G981. https://doi.org/10.1152/ajpgi.00072.2021
-
Liu, Y., Tran, D.Q., Fatheree, N.Y. and Rhoads, J.M., 2014. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. American Journal of Physiology â Gastrointestinal and Liver Physiology 307: G177-G186. https://doi.org/10.1152/ajpgi.00038.2014
-
Lo Vecchio, A., Vandenplas, Y., Benninga, M., Broekaert, I., Falconer, J., Gottrand, F., Lifschitz, C., Lionetti, P., Orel, R., Papadopoulou, A., Ribes-Koninckx, C., Salvatore, S., Shamir, R., Schäppi, M., Staiano, A., Szajewska, H., Thapar, N., Wilschanski, M., Guarino, A., 2016. An international consensus report on a new algorithm for the management of infant diarrhoea. Acta Paediatrica 105: e384-e389. https://doi.org/10.1111/apa.13432
-
Maccelli, A., Carradori, S., Puca, V., Sisto, F., Lanuti, P., Crestoni, M.E., Lasalvia, A., Muraro, R., Bysell, H., Sotto, A. Di, Roos, S. and Grande, R., 2020. Correlation between the antimicrobial activity and metabolic profiles of cell free supernatants and membrane vesicles produced by Lactobacillus reuteri DSM 17938. Microorganisms 8: 1653. https://doi.org/10.3390/microorganisms8111653
-
Malfertheiner, P., Megraud, F., OâMorain, C.A., Gisbert, J.P., Kuipers, D. J., Axon, A.T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D.Y., Hunt, R., Moayyedi, P., Rokkas, T., Rugge, M., Selgrad, M., Suerbaum, S., Sugano, K. and El-Omar, E.M., 2012. Management of Helicobacter pylori infection â The Maastricht IV/Florence consensus report. Gut 61: 646-664. https://doi.org/10.1136/gutjnl-2012-302084
-
Mangalat, N., Liu, Y., Fatheree, N.Y., Ferris, M.J., van Arsdall, M.R., Chen, Z., Rahbar, M.H., Gleason, W.A., Norori, J., Tran, D.Q. and Rhoads, J.M., 2012. Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial. PloS One 7: e43910. https://doi.org/10.1371/J0URNAL.PONE.0043910
-
Maragkoudaki, M., Chouliaras, G., Moutafi, A., Thomas, A., Orfanakou, A. and Papadopoulou, A., 2018. Efficacy of an oral rehydration solution enriched with Lactobacillus reuteri DSM 17938 and zinc in the management of acute diarrhoea in infants: a randomized, double-blind, placebo-controlled trial. Nutrients 10: 1189. https://doi.org/10.3390/nu10091189
-
Maragkoudaki, M., Chouliaras, G., Orel, R., Horvath, A., Szajewska, H. and Papadopoulou, A., 2017. Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Acta Paediatrica 106: 1857-1862. https://doi.org/10.1111/apa.13992
-
Mata Forsberg, M., Björkander, S., Pang, Y., Lundqvist, L., Ndi, M., Ott, M., Escribá, I.B., Jaeger, M.C., Roos, S. and Sverremark-Ekström, E., 2019. Extracellular membrane vesicles from lactobacilli dampen IFN-γ responses in a monocyte-dependent manner. Scientific Reports 9: 17109. https://doi.org/10.1038/s41598-019-53576-6
-
Merenstein, D., Salminen, S., and the WGO Review Team, 2017. World Gastroenterology Organisation Global Guidelines â Probiotics and prebiotics. World Gastroenterology Organisation. Available at: https://tinyurl.com/2p89ckr2
-
Mi, G.L., Zhao, L., Qiao, D.D., Kang, W.Q., Tang, M.Q. and Xu, J.K., 2015. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie van Leeuwenhoek 107: 1547-1553. https://doi.org/10.1007/s10482-015-0448-9
-
Mu, Q., Tavella, V.J. and Luo X.M., 2018. Role of Lactobacillus reuteri in human health and diseases. Frontiers in Microbiology 9: 757. https://doi.org/10.3389/fmicb.2018.00757
-
Nelson, S.P., Chen, E.H., Syniar, G.M. and Christoffel, K.K., 1997. Prevalence of symptoms of gastroesophageal reflux during infancy: a pediatric practice-based survey. Archives of Pediatrics and Adolescent Medicine 151: 569-572. https://doi.org/10.1001/archpedi.1997.02170430035007
-
Nocturne, G., Pontarini, E., Bombardieri, M. and Mariette, X., 2019. Lymphomas complicating primary Sjögrenâs syndrome: from autoimmunity to lymphoma. Rheumatology 60: 3513-3521. https://doi.org/10.1093/rheumatology/kez052
-
Oberhelman, R.A., Kosek, M.N., Peñataro-Yori, P., Paredes-Olórtegui and M., Connolly, E., 2014. Short report: A phase one safety study of Lactobacillus reuteri conducted in the Peruvian Amazon: observations from the field. American Journal of Tropical Medicine and Hygiene 90: 777-780. https://doi.org/10.4269/ajtmh.13-0639
-
Ohkusa, T., Koido, S., Nishikawa, Y. and Sato, N., 2019. Gut microbiota and chronic constipation: a review and update. Frontiers in Medicine 6: 19. https://doi.org/10.3389/fmed.2019.00019
-
Ojetti, V., Ianiro, G., Tortora, A., DâAngelo, G., di Rienzo, T.A., Bibbò, S., Migneco, A. and Gasbarrini, A., 2014. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. Journal of Gastrointestinal and Liver Diseases 23: 387-391. https://doi.org/10.15403/jgld.2014.1121.234.elr
-
Oliveira, A.P., Souza, L.K.M., Araújo, T.S.L., de Araújo, S., Nogueira, K.M., Sousa, F.B.M., Silva, R.O., PacÃfico, D.M., Martins, C.S., De C. Brito, G.A.., Souza, M.H.L.P. and Medeiros, J.V.R., 2019. Lactobacillus reuteri DSM 17938 protects against gastric damage induced by ethanol administration in mice: role of TRPV1/substance P axis. Nutrients 11: 208. https://doi.org/10.3390/nu11010208
-
Paydas, S., 2015. Helicobacter pylori eradication in gastric diffuse large B cell lymphoma. World Journal of Gastroenterology 21: 3773-3776. https://doi.org/10.3748/WJG.V21.I13.3773
-
Perez-Burgos, A., Wang, L., Mcvey Neufeld, K.A., Mao, Y.K., Ahmadzai, M., Janssen, L.J., Stanisz, A.M., Bienenstock, J. and Kunze, W.A., 2015. The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. Journal of Physiology 593: 3943-3957. https://doi.org/10.1113/JP270229
-
Pittet, D., Allegranzi, B. and Boyce, J., 2009. The World Health Organization Guidelines on hand hygiene in health care and their consensus recommendations. Infection Control and Hospital Epidemiology 30: 611-622. https://doi.org/10.1086/600379
-
Posfay-Barbe, K.M., Zerr, D.M. and Pittet, D., 2008. Infection control in paediatrics. The Lancet Infectious Diseases 8: 19-31. https://doi.org/10.1016/S1473-3099(07)70310-9
-
Preidis, G.A., Saulnier, D.M., Blutt, S.E., Mistretta, T., Riehle, K.P., Major, A.M., Venable, S.F., Finegold, M.J., Petrosino, J.F., Conner, M. E. and Versalovic, J., 2012. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB Journal 26: 1960-1969. https://doi.org/10.1096/FJ.10-177980
-
Raju, R., Gadakh, S., Gopal, P., George, B., Advani, J., Soman, S., Prasad, T.S.K. and Girijadevi, R., 2015. Differential ligand-signaling network of CCL19/CCL21-CCR7 system. Database 2015: bav106. https://doi.org/10.1093/DATABASE/BAV106
-
Riezzo, G., Chimienti, G., Orlando, A., DâAttoma, B., Clemente, C. and Russo, F., 2019. Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation. Beneficial Microbes 10: 137-147. https://doi.org/10.3920/BM2018.0050
-
Riezzo, G., Orlando, A., DâAttoma, B., Linsalata, M., Martulli, M. and Russo, F., 2018. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: Improvement in symptoms and bowel habit in functional constipation. Beneficial Microbes 9: 51-60. https://doi.org/10.3920/BM2017.0049
-
Romano, C., Ferrauâ, V., Cavataio, F., Iacono, G., Spina, M., Lionetti, E., Comisi, F., Famiani, A. and Comito, D., 2014. Lactobacillus reuteri in children with functional abdominal pain (FAP). Journal of Paediatrics and Child Health 50: E68-E71. https://doi.org/10.1111/j.1440-1754.2010.01797.x
-
Rosander, A., Connolly, E. and Roos, S., 2008. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Applied and Environmental Microbiology 74: 6032-6040. https://doi.org/10.1128/AEM.00991-08
-
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., Dilorenzo, C., Gottrand, F., Gupta, S., Langendam, M., Staiano, A., Thapar, N., Tipnis, N. and Tabbers, M., 2018. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutritio. Journal of Pediatric Gastroenterology and Nutrition 66: 516-554. https://doi.org/10.1097/MPG.0000000000001889
-
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.F., Ardid, D. and Desreumaux, P., 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 13: 35-37. https://doi.org/10.1038/nm1521
-
Salari, P., Nikfar, S. and Abdollahi, M., 2012. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflammation and Allergy â Drug Targets 11: 3-14. https://doi.org/10.2174/187152812798889394
-
Saulnier, D.M., Riehle, K., Mistretta, T.A., Diaz, M.A., Mandal, D., Raza, S., Weidler, E.M., Qin, X., Coarfa, C., Milosavljevic, A., Petrosino, J.F., Highlander, S., Gibbs, R., Lynch, S. V., Shulman, R.J. and Versalovic, J., 2011. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141: 1782-1791. https://doi.org/10.1053/J.GASTRO.2011.06.072
-
Savino, F., Ceratto, S., Poggi, E., Cartosio, M.E., Cordero di Montezemolo, L. and Giannattasio, A., 2015. Preventive effects of oral probiotic on infantile colic: A prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938. Beneficial Microbes 6: 245-251. https://doi.org/10.3920/BM2014.0090
-
Savino, F., Cordisco, L., Tarasco, V., Palumeri, E., Calabrese, R., Oggero, R., Roos, S. and Matteuzzi, D., 2010. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebocontrolled trial. Pediatrics 126: e526-e533. https://doi.org/10.1542/peds.2010-0433
-
Savino, F., Galliano, I., Garro, M., Savino, A., Daprà , V., Montanari, P. and Bergallo, M., 2018a. Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with Lactobacillus reuteri DSM17938. Beneficial Microbes 9: 917-925. https://doi.org/10.3920/BM2017.0194
-
Savino, F., Galliano, I., Savino, A., Daprà , V., Montanari, P., Calvi, C. and Bergallo, M., 2019. Lactobacillus reuteri DSM 17938 probiotics may increase CC-chemokine receptor 7 expression in infants treated with for colic. Frontiers in Pediatrics 7: 292. https://doi.org/10.3389/fped.2019.00292
-
Savino, F., Garro, M., Montanari, P., Galliano, I. and Bergallo, M., 2018b. Crying time and RORγ/FOXP3 expression in Lactobacillus reuteri DSM17938-treated infants with colic: a randomized trial. Journal of Pediatrics 192: P171-177.e1. https://doi.org/10.1016/j.jpeds.2017.08.062
-
Savino, F., Pelle, E., Palumeri, E., Oggero, R. and Miniero, R., 2007. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119: https://doi.org/10.1542/PEDS.2006-1222
-
Sherman, P.M., Hassall, E., Fagundes-Neto, U., Gold, B.D., Kato, S., Koletzko, S., Orenstein, S., Rudolph, C., Vakil, N. and Vandenplas, Y., 2009. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. American Journal of Gastroenterology 104: 1278-1295. https://doi.org/10.1038/ajg.2009.129
-
Smart, J. and Hiscock, H., 2007. Early infant crying and sleeping problems: a pilot study of impact on parental well-being and parent-endorsed strategies for management. Journal of Paediatrics and Child Health 43: 284-290. https://doi.org/10.1111/j.1440-1754.2007.01060.x
-
Sung, V., DâAmico, F., Cabana, M.D., Chau, K., Koren, G., Savino, F., Szajewska, H., Deshpande, G., Dupont, C., Indrio, F., Mentula, S., Partty, A. and Tancredi, D., 2018. Lactobacillus reuteri to treat infant colic: a meta-analysis. Pediatrics 141: https://doi.org/10.1542/peds.2017-1811
-
Sung, V., Hiscock, H., Tang, M.L.K., Mensah, F.K., Nation, M.L., Satzke, C., Heine, R.G., Stock, A., Barr, R.G. and Wake, M., 2014. Treating infant colic with the probiotic Lactobacillus reuteri: Double blind, placebo controlled randomised trial. BMJ 348: g2107-g2107. https://doi.org/10.1136/bmj.g2107
-
Szajewska, H., Canani, R.B., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., Van Goudoever, J.B. and Weizman, Z., 2016. Probiotics for the prevention of antibiotic-associated diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition 62: 495-506. https://doi.org/10.1097/MPG.0000000000001081
-
Szajewska, H., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Salvatore, S., Shamir, R., van Goudoever, J.B., Vandenplas, Y., Weizman, Z. and Zalewski, B.M., 2020. Use of probiotics for the management of acute gastroenteritis in children: an update. Journal of Pediatric Gastroenterology and Nutrition 71: 261-269. https://doi.org/10.1097/MPG.0000000000002751
-
Szajewska, H., Gyrczuk, E. and Horvath, A., 2013. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. Journal of Pediatrics 162: 257-262. https://doi.org/10.1016/j.jpeds.2012.08.004
-
Szajewska, H. and Kolodziej, M., 2015a. Systematic review with metaanalysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology and Therapeutics 42: 793-801. https://doi.org/10.1111/apt.13344
-
Szajewska, H. and Kolodziej, M., 2015b. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Alimentary Pharmacology and Therapeutics 42: 1149-1157. https://doi.org/10.1111/APT.13404
-
Szajewska, H., UrbaÅska, M., Chmielewska, A., Weizman, Z. and Shamir, R., 2014. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Beneficial Microbes 5: 285-293. https://doi.org/10.3920/BM2013.0056
-
SzymaÅski, H. and Szajewska, H., 2019. Lack of efficacy of Lactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis: a randomized controlled trial. Pediatric Infectious Disease Journal 38: E237-E242. https://doi.org/10.1097/INF.0000000000002355
-
Tong, J.L., Ran, Z.H., Shen, J., Zhang, C.X. and Xiao, S.D., 2007. Metaanalysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics 25: 155-168. https://doi.org/10.1111/j.1365-2036.2006.03179.x
-
TriviÄ, I., Niseteo, T., JadreÅ¡in, O. and Hojsak, I., 2021. Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis. European Journal of Pediatrics 180: 339-351. https://doi.org/10.1007/S00431-020-03809-Y
-
Turck, D, Bernet, J.P., Marx, J., Kempf, H, Giard, P., Walbaum, O., Lacombe, A., Rembert, F., Toursel, F., Bernasconi, P., Gottrand, F., McFarland, L.V. and Bloch, K., 2003. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. Journal of Pediatric Gastroenterology and Nutrition 37: 22-26. https://doi.org/10.1097/00005176-200307000-00004
-
UrbaÅska, M., Gieruszczak-BiaÅek, D. and Szajewska, H., 2016. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Alimentary Pharmacology and Therapeutics 43: 1025-1034. https://doi.org/10.1111/apt.13590
-
Vandenplas, Y., Alarcon, P., Alliet, P., De Greef, E., De Ronne, N., Hoffman, I., Van Winckel, M. and Hauser, B., 2015. Algorithms for managing infant constipation, colic, regurgitation and cowâs milk allergy in formula-fed infants. Acta Paediatrica 104: 449-457. https://doi.org/10.1111/apa.12962
-
Wanke, M. and Szajewska, H., 2012. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. Journal of Pediatrics 161: 40-43.e1. https://doi.org/10.1016/j.jpeds.2011.12.049
-
Wegner, A., Banaszkiewicz, A., Kierkus, J., Landowski, P., Korlatowicz-Bilar, A., Wiecek, S., Kwiecien, J., Gawronska, A., Dembinski, L., Czaja-Bulsa, G. and Socha, P., 2018. The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial. Clinics and Research in Hepatology and Gastroenterology 42: 494-500. https://doi.org/10.1016/j.clinre.2018.03.008
-
Weizman, Z., Abu-Abed, J. and Binsztok, M., 2016. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. Journal of Pediatrics 174: 160-164.e1. https://doi.org/10.1016/j.jpeds.2016.04.003
-
Weizman, Z., Asli, G. and Alsheikh, A., 2005. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics 115: 5-9. https://doi.org/10.1542/peds.2004-1815
-
Wessel, M.A., Cobb, J.C., Jackson, E.B., Harris, G.S. and Detwiler, A.C., 1954. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics 14: 421-435.
'Paroxysmal fussing in infancy, sometimes called colic ' () 14 Pediatrics : 421 -435.
-
West, C.L., Stanisz, A.M., Mao, Y.K., Champagne-Jorgensen, K., Bienenstock, J. and Kunze, W.A., 2020. Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice. PLoS ONE 15: e0225481. https://doi.org/10.1371/journal.pone.0225481
-
Wolf, B.W., Garleb, K.A., Ataya, D.G. and Casas, I.A., 1995. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microbial Ecology in Health and Disease 8: 41-50. https://doi.org/10.3109/08910609509141381
-
Wolf, B.W., Wheeler, K.B., Ataya, D.G. and Garleb, K.A., 1998. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food and Chemical Toxicology 36: 1085-1094. https://doi.org/10.1016/S0278-6915(98)00090-8
-
World Health Organization (WHO), 2011. Report on the burden of endemic health care-associated infection worldwide. WHO Library Cataloguing-in-Publication Data 40. Available at: https://tinyurl.com/tfrexwjd.
-
Wu, R.Y., Pasyk, M., Wang, B., Forsythe, P., Bienenstock, J., Mao, Y.K., Sharma, P., Stanisz, A.M. and Kunze, W.A., 2013. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterology and Motility 25: e205-e214. https://doi.org/10.1111/nmo.12072
-
Xu, M., Wang, J., Wang, N., Sun, F., Wang, L. and Liu, X.H., 2015. The efficacy and safety of the probiotic bacterium Lactobacillus reuteri DSM 17938 for infantile colic: a meta-analysis of randomized controlled trials. PLoS ONE 10: e0141445. https://doi.org/10.1371/journal.pone.0141445
-
Youssef, N.N., Murphy, T.G., Langseder, A.L. and Rosh, J.R., 2006. Quality of life for children with functional abdominal pain: a comparison study of patientsâ and parentsâ perceptions. Pediatrics 117: 54-59. https://doi.org/10.1542/peds.2005-0114
-
Zhao, Y. and Yu, Y.B., 2016. Intestinal microbiota and chronic constipation. SpringerPlus 5: 1130. https://doi.org/10.1186/s40064-016-2821-1
-
Zheng, J., Wittouck, S., Salvetti, E., Franz, C., Harris, H., Mattarelli, P., OâToole, P. W., Pot, B., Vandamme, P., Walter, J., Watanabe, K., Wuyts, S., Felis, G. E., Gänzle, M. G. and Lebeer, S., 2020. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. International Journal of Systematic and Evolutionary Microbiology 70: 2782-2858. https://doi.org/10.1099/ijsem.0.004107
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 2208 | 492 | 39 |
| å ¨ææµè§æ¬¡æ° | 45 | 8 | 0 |
| PDFä¸è½½æ¬¡æ° | 79 | 18 | 0 |
Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review
äºBeneficial MicrobesSearch for other papers by V.N. Dargenio in
Current site
Google Scholar
PubMed
Search for other papers by F. Cristofori in
Current site
Google Scholar
PubMed
Search for other papers by C. Dargenio in
Current site
Google Scholar
PubMed
Search for other papers by P. Giordano in
Current site
Google Scholar
PubMed
Search for other papers by F. Indrio in
Current site
Google Scholar
PubMed
Search for other papers by G. Celano in
Current site
Google Scholar
PubMed
Search for other papers by R. Francavilla in
Current site
Google Scholar
PubMed
Strains of lactobacilli are the most widely used probiotics and can be found in a large variety of food products and food supplements throughout the world. In this study, the evidence on Limosilactobacillus reuteri DSM 17938 (LR DSM 17938) has been reviewed. This species secretes reuterin and other substances singularly or in microvesicles, inhibiting pathogen growth and interacting with the intestinal microbiota and mucosa, restoring homeostasis. The use of LR DSM 17938 has been exploited in several pathological conditions. Preclinical research has shown that this probiotic can ameliorate dysbiosis and, by interacting with intestinal mucosal cells, can raise the pain threshold and promote gastrointestinal motility. These aspects are amongst the significant components in functional gastrointestinal disorders, such as colic and regurgitation in infants, functional abdominal pain and functional constipation in children and adolescents. This strain can decrease the duration of acute diarrhoea and hospitalization for acute gastroenteritis but does not seem to prevent nosocomial diarrhoea and antibiotic-associated diarrhoea. Because of its ability to survive in the gastric environment, it has been tested in Helicobacter pylori infection, showing a significant decrease of antibiotic-associated side effects and a tendency to increase the eradication rate. Finally, all these studies have shown the excellent safety of LR DSM 17938 even at higher dosages. In conclusion data from various clinical trials here reviewed can guide the clinician to find the correct dose, frequency of administration, and therapy duration.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 2208 | 492 | 39 |
| å ¨ææµè§æ¬¡æ° | 45 | 8 | 0 |
| PDFä¸è½½æ¬¡æ° | 79 | 18 | 0 |
